NFKB1 and gastric cancer: Based on these conclusions, we confirm that Ubenimex can reverse CDDP resistance and enhance CDDP-sensitivity by inhibiting the activation of the CD13/EMP3/PI3K/AKT/NF-κB pathway in GC cells.